MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

David T. Rubin  1     Paul F. Pollock  2     Theresa Hunter  2     Mingyang Shan  2     Lai Shan Chan  2     Deanilee Deckard  2    
1 University of Chicago Medicine, Chicago, United States
2 Eli Lilly and Company, Indianapolis, United States

Topic
IBD, Immunology, Paediatrics

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing